RPT-BRIEF-Emergent Biosolutions to expand clinical trial of TRU-016 and ... Reuters April 5 (Reuters) - April 5 (Reuters) - Emergent Biosolutions Inc : * To expand front line CLL clinical trial of TRU-016 and rituximab based on strong patient enrollment and encouraging early clinical data * Source text for Eikon * Further company ... |
